Study Summary
This trial aims to understand how the brain processes & controls speech in healthy people. 15 participants will do 4 visits of 2-4 hrs each to help people with communication disorders.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: up to 1 hour
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Healthy Adult Speakers
1 of 1
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: Healthy Adult Speakers · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 70 · All Participants · 13 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does this research endeavor accommodate participants aged 55 and above?
"To be eligible for this study, applicants should fall within the 18 to 70-year-old age range. For those under 18 and over 65 years old, separate trials have been established with a total of 5 in all." - Anonymous Online Contributor
Is this research endeavor accepting participants currently?
"According to the most recent update on clinicaltrials.gov, this medical trial is still in search of suitable applicants. It was first announced on November 18th 2022 and has been ammended as recently as February 1st 2023." - Anonymous Online Contributor
How many participants are actively engaged in this clinical endeavor?
"Affirmative. The relevant data on clinicaltrials.gov suggests that this research is presently recruiting participants, with 15 patients needed from a single site since it was first posted on November 18th 2022 and most recently updated February 1st 2023." - Anonymous Online Contributor
What qualifications must I meet to participate in this research?
"Fifteen adults, ranging in age from 18 to 70 years old and who are English-speaking with normal hearing and speech abilities, as well as no history of stroke or neurological issues may be eligible for this clinical trial regarding the development of speech." - Anonymous Online Contributor